These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18588562)

  • 21. Evaluation of allergen vaccine potency.
    Esch RE
    Curr Allergy Asthma Rep; 2006 Sep; 6(5):402-6. PubMed ID: 16899202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allergen immunotherapy: a long-term perspective.
    Patterson R; Grammer LC
    Ann Allergy Asthma Immunol; 1999 Apr; 82(4):315-6. PubMed ID: 10227330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Desensitization with allergens: early, specific, effective therapy of immune system almost without side effects. Interview by Dr. Barbara Scholtissek].
    Fiebig H; Kahlert H
    Wien Med Wochenschr; 1999; 149(14-15):447, 449-50. PubMed ID: 10584292
    [No Abstract]   [Full Text] [Related]  

  • 24. [Governmental batch sample testing of allergen products].
    Bartel D; Führer F; Vieths S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):358-62. PubMed ID: 22373849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safe allergen immunotherapy. The correct allergen, the appropriate patient, the adequate dose.
    Schoenwetter WF
    Postgrad Med; 1996 Aug; 100(2):123-6, 131-5. PubMed ID: 8700812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and characteristics of biphasic reactions after allergen immunotherapy.
    Scranton SE; Gonzalez EG; Waibel KH
    J Allergy Clin Immunol; 2009 Feb; 123(2):493-8. PubMed ID: 19064282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcutaneous administration of allergen vaccines.
    Radtke M; Grammer LC
    Clin Allergy Immunol; 2008; 21():321-32. PubMed ID: 18828514
    [No Abstract]   [Full Text] [Related]  

  • 28. Current concepts in allergen immunotherapy.
    Stone D; Imbeau S; Moyer J
    J S C Med Assoc; 2000 May; 96(5):218-20. PubMed ID: 10850024
    [No Abstract]   [Full Text] [Related]  

  • 29. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality and clinical efficacy of allergen mixtures.
    Malling HJ
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):253-7; discussion 257. PubMed ID: 17393747
    [No Abstract]   [Full Text] [Related]  

  • 31. Are we following practice parameter guidelines on allergen immunotherapy?
    Chacko T
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):178. PubMed ID: 18320926
    [No Abstract]   [Full Text] [Related]  

  • 32. Allergen stability of testing/treatment boards and immunotherapy vials with various diluents.
    Nida A; Leatherman B; Plunkett G; Mire B
    Int Forum Allergy Rhinol; 2015 Nov; 5(11):1028-35. PubMed ID: 26153653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EAACI guidelines on allergen immunotherapy: Executive statement.
    Muraro A; Roberts G; Halken S; Agache I; Angier E; Fernandez-Rivas M; Gerth van Wijk R; Jutel M; Lau S; Pajno G; Pfaar O; Ryan D; Sturm GJ; van Ree R; Varga EM; Bachert C; Calderon M; Canonica GW; Durham SR; Malling HJ; Wahn U; Sheikh A
    Allergy; 2018 Apr; 73(4):739-743. PubMed ID: 29380390
    [No Abstract]   [Full Text] [Related]  

  • 34. EAACI guidelines on allergen immunotherapy-Out with the old and in with the new.
    Agache I
    Allergy; 2018 Apr; 73(4):737-738. PubMed ID: 29319886
    [No Abstract]   [Full Text] [Related]  

  • 35. Subcutaneous immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases.
    Malling HJ; Bousquet J
    Clin Allergy Immunol; 2008; 21():343-58. PubMed ID: 18828516
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunotherapy preparation guidelines, rules, and regulation.
    Esch RE; Plunkett GA
    Curr Allergy Asthma Rep; 2013 Aug; 13(4):406-13. PubMed ID: 23722699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allergen injection immunotherapy (hyposensitization) on trial.
    Kay AB
    Clin Exp Allergy; 1989 Nov; 19(6):591-6. PubMed ID: 2598099
    [No Abstract]   [Full Text] [Related]  

  • 38. Unproven and controversial forms of immunotherapy.
    Terr AI; Tcheurekdjian H
    Clin Allergy Immunol; 2008; 21():447-53. PubMed ID: 18828522
    [No Abstract]   [Full Text] [Related]  

  • 39. Advantages and disadvantages of accelerated immunotherapy schedules.
    Cox L
    J Allergy Clin Immunol; 2008 Aug; 122(2):432-4. PubMed ID: 18619664
    [No Abstract]   [Full Text] [Related]  

  • 40. [Allergen extracts. New principles and time indicated products].
    Aas K
    Tidsskr Nor Laegeforen; 1977 Dec; 97(34-36):1809-11. PubMed ID: 594989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.